Bone marrow mesenchymal stem cells-derived exosomes combined with chondroitinase ABC for treating spinal cord injury in rats

doi:10.12307/2022.004

Abstract

Abstract: BACKGROUND: How to improve the local microenvironment, inhibit the formation of the glial scar, and promote repair and regeneration of damaged neurons and axons, are the difficulties of treating spinal cord injury. The research demonstrated that chondroitinase ABC can enhance the regeneration and plasticity of axons by degrading chondroitin sulfate proteoglycans. Meanwhile, bone marrow mesenchymal stem cells-derived exosome has a protective effect on spinal cord injury recovery by inhibiting apoptosis, regulating immune response, and regulating regeneration of damaged neurons.
OBJECTIVE: To investigate the repair effect of bone marrow mesenchymal stem cells-derived exosome combined with chondroitinase ABC on spinal cord injury in rats and to explore its mechanism.
METHODS: Using the exosomes-extracted kit to isolate bone marrow mesenchymal stem cells-derived exosome, its morphology was observed under a transmission electron microscope. The expression levels of CD63 and Alix were identified through western blot assay. Totally 50 SD rats were randomly divided into five groups: sham group, model group, chondroitinase ABC group, exosome group, and combination group, with 10 rats in each group. Rat models of spinal cord injury were established by referencing the modified Allen’s method. In the chondroitinase ABC group and combination group, a micro syringe was applied to directly inject chondroitinase ABC into the injured area. At 2 hours after surgery, the models of the exosome group and the combination group were injected with bone marrow mesenchymal stem cells-derived exosomes through the tail vein, once every 2 days, for a total of 3 injections. The hind limb motor function was scored at 1, 3, 7, 14, and 28 days after surgery. At 14 days, six rats were taken from each group to make paraffin slices after perfusion. The pathological changes were observed at the injury region by hematoxylin-eosin staining. The expression of glial fibrillary acidic protein was detected by immunofluorescence and the expression of growth-associated protein-43 was identified by immunohistochemistry.
RESULTS AND CONCLUSION: (1) The exosomes presented a circular or elliptical shape or “saucer-like” and its size was uneven. The positive expression of its marker proteins CD63 and Alix could be observed. (2) Compared with the model, chondroitinase ABC, and exosome groups, BBB score was higher; damaged area was smaller; expression of glial fibrillary acidic protein was lower; the expression of growth-associated protein-43 was up-regulated in the combination group (all P < 0.05). (3) The results demonstrate that bone marrow mesenchymal stem cells-derived exosome combined with chondroitinase ABC can inhibit the expression of glial fibrillary acidic protein in the injured area, up-regulate the expression of growth-associated protein-43, and reduce the formation of the glial scar, which improve local microenvironment and promote the repair and regeneration of neurons and axons after spinal cord injury in rats.

Key words: stem cells, bone marrow mesenchymal stem cells, exosomes, chondroitinase ABC, spinal cord injury, repair and regeneration, tissue engineering, glial fibrillary acidic protein, growth-associated protein-43

CLC Number:

Xie Xingqi, Hu Wei, Tu Guanjun. Bone marrow mesenchymal stem cells-derived exosomes combined with chondroitinase ABC for treating spinal cord injury in rats[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(1): 20-26.

Figures/Tables 7

References

[1] ECKERT MJ, MARTIN MJ. Trauma: Spinal Cord Injury. Surg Clin North Am. 2017;97(5):1031-1045.
[2] 吴周睿,朱元贵,程黎明,等.SCI与修复的关键科学问题——第81期“双清论坛”综述[J].中国科学基金,2013,27(3):147-153.
[3] LEE H, MCKEON RJ, BELLAMKONDA RV. Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci U S A. 2010;107(8): 3340-3345.
[4] BRADBURY EJ, CARTER LM. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull. 2011;84(4-5):306-316.
[5] TESTER NJ, PLAAS AH, HOWLAND DR. Effect of body temperature on chondroitinase ABC’s ability to cleave chondroitin sulfate glycosaminoglycans. J Neurosci Res. 2007;85(5):1110-1118.
[6] MORTAZAVI MM, HARMON OA, ADEEB N, et al. Treatment of spinal cord injury: a review of engineering using neural and mesenchymal stem cells. Clin Anat. 2015;28(1):37-44.
[7] FILIPPI M, BOIDO M, PASQUINO C, et al. Successful in vivo MRI tracking of MSCs labeled with Gadoteridol in a Spinal Cord Injury experimental model. Exp Neurol. 2016;282:66-77.
[8] BOIDO M, RUPA R, GARBOSSA D, et al. Embryonic and adult stem cells promote raphespinal axon outgrowth and improve functional outcome following spinal hemisection in mice. Eur J Neurosci. 2009;30(5):833-846.
[9] ZACHAR L, BAČENKOVÁ D, ROSOCHA J. Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment. J Inflamm Res. 2016;9:231-240.
[10] COFANO F, BOIDO M, MONTICELLI M, et al. Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy. Int J Mol Sci. 2019;20(11):2698.
[11] CHEN X, LI Y, WANG L, et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology. 2002; 22(4):275-279.
[12] THÉRY C, ZITVOGEL L, AMIGORENA S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569-579.
[13] 万然,史旭,刘京松,等.间充质干细胞分泌组治疗SCI的研究进展[J].中国组织工程研究,2021,25(7):1088-1095.
[14] REN Z, QI Y, SUN S, et al. Mesenchymal Stem Cell-Derived Exosomes: Hope for Spinal Cord Injury Repair. Stem Cells Dev. 2020;29(23):1467-1478.
[15] ALLEN AR. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocaion of spinal colum. JAMA. 1911;57(4): 878-880.
[16] 王琳,裴双,郭斌,等.骨髓间充质干细胞来源的外泌体用于大鼠SCI修复的初步探索[J].中国病理生理杂志,2018,34(5):862-869.
[17] GOLDSTEIN M, WATKINS S. Immunohistochemistry. Curr Protoc Mol Biol. 2008;Chapter 14:Unit 14.6.
[18] GAZDIC M, VOLAREVIC V, HARRELL CR, et al. Stem Cells Therapy for Spinal Cord Injury. Int J Mol Sci. 2018;19(4):1039.
[19] LIU AM, CHEN BL, YU LT, et al. Human adipose tissue- and umbilical cord-derived stem cells: which is a better alternative to treat spinal cord injury? Neural Regen Res. 2020;15(12):2306-2317.
[20] JIN MC, MEDRESS ZA, AZAD TD, et al. Stem cell therapies for acute spinal cord injury in humans: a review. Neurosurg Focus. 2019;46(3):E10.
[21] CSOBONYEIOVA M, POLAK S, ZAMBORSKY R, et al. Recent Progress in the Regeneration of Spinal Cord Injuries by Induced Pluripotent Stem Cells. Int J Mol Sci. 2019;20(15):3838.
[22] CURTIS E, MARTIN JR, GABEL B, et al. A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury. Cell Stem Cell. 2018;22(6):941-950.e6.
[23] LIAU LL, LOOI QH, CHIA WC, et al. Treatment of spinal cord injury with mesenchymal stem cells. Cell Biosci. 2020;10:112.
[24] SHENDE P, SUBEDI M. Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury. Biomed Pharmacother. 2017;91:693-706.
[25] ZURITA M, VAQUERO J. Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation. Neuroreport. 2004; 15(7):1105-1108.
[26] PAUL C, SAMDANI AF, BETZ RR, et al. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine (Phila Pa 1976). 2009;34(4):328-334.
[27] VAQUERO J, ZURITA M, OYA S, et al. Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration? Neurosci Lett. 2006;398(1-2):129-134.
[28] HELDRING N, MÄGER I, WOOD MJ, et al. Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles. Hum Gene Ther. 2015;26(8):506-517.
[29] BAGNO L, HATZISTERGOS KE, BALKAN W, et al. Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges. Mol Ther. 2018;26(7):1610-1623.
[30] LOU G, CHEN Z, ZHENG M, et al. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49(6):e346.
[31] FORSBERG MH, KINK JA, HEMATTI P, et al. Mesenchymal stromal cells and exo: progress and challenges. Front Cell Dev Biol. 2020;8:665.
[32] ZHANG Y, WANG WT, GONG CR, et al. Combination of olfactory ensheathing cells and human umbilical cord mesenchymal stem cell-derived exosomes promotes sciatic nerve regeneration. Neural Regen Res. 2020;15(10):1903-1911.
[33] LIEW LC, KATSUDA T, GAILHOUSTE L, et al. Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer’s disease. Int Immunol. 2017;29(1):11-19.
[34] LIU W, WANG Y, GONG F, et al. Exosomes derived from bone mesenchymal stem cells repair traumatic spinal cord injury by suppressing the activation of A1 neurotoxic reactive astrocytes. J Neurotrauma. 2019;36(3):469-484.
[35] ZHAO C, ZHOU X, QIU J, et al. Exosomes derived from bone marrow mesenchymal stem cells inhibit complement activation in rats with spinal cord injury. Drug Des Devel Ther. 2019;13:3693-3704.
[36] LANKFORD KL, ARROYO EJ, NAZIMEK K, et al. Intravenously delivered mesenchymal stem cell-derived exosomes target M2-type macrophages in the injured spinal cord. PLoS One. 2018;13(1):e0190358.
[37] LI C, JIAO G, WU W, et al. Exosomes from bone marrow mesenchymal stem cells inhibit neuronal apoptosis and promote motor function recovery via the wnt/β-catenin signaling pathway. Cell Transplant. 2019;28(11):1373-1383.
[38] PEKNY M, PEKNA M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol. 2004;204(4):428-437.
[39] 熊薇,袁娅金,张桂仙,等.中枢神经系统损伤后胶质瘢痕形成的机制及其对神经修复的影响[J].中国细胞生物学学报,2020,42(10): 1876-1883.
[40] AZIZI M, FARAHMANDGHAVI F, JOGHATAEI MT, et al. ChABC-loaded PLGA nanoparticles: A comprehensive study on biocompatibility, functional recovery, and axonal regeneration in animal model of spinal cord injury. Int J Pharm. 2020;577:119037.
[41] XIA T, HUANG B, NI S, et al. The combination of db-cAMP and ChABC with poly(propylene carbonate) microfibers promote axonal regenerative sprouting and functional recovery after spinal cord hemisection injury. Biomed Pharmacother. 2017;86:354-362.
[42] LIU X, WANG J, LI G, et al. Effect of combined chondroitinase ABC and hyperbaric oxygen therapy in a rat model of spinal cord injury. Mol Med Rep. 2018;18(1):25-30.
[43] FÜHRMANN T, ANANDAKUMARAN PN, PAYNE SL, et al. Combined delivery of chondroitinase ABC and human induced pluripotent stem cell-derived neuroepithelial cells promote tissue repair in an animal model of spinal cord injury. Biomed Mater. 2018;13(2):024103.
[44] JANZADEH A, SARVEAZAD A, YOUSEFIFARD M, et al. Combine effect of chondroitinase ABC and low level laser (660nm) on spinal cord injury model in adult male rats. Neuropeptides. 2017;65:90-99.
[45] SARVEAZAD A, BABAHAJIAN A, BAKHTIARI M, et al. The combined application of human adipose derived stem cells and chondroitinase ABC in treatment of a spinal cord injury model. Neuropeptides. 2017;61:39-47.
[46] NOVOTNA I, SLOVINSKA L, VANICKY I, et al. IT delivery of ChABC modulates NG2 and promotes GAP-43 axonal regrowth after spinal cord injury. Cell Mol Neurobiol. 2011;31(8):1129-1139.

(责任编辑：MZH，ZN，JY)